Clinical trials: Axial Spondyloarthritis
Ankylosing Spondylitis
Neuropathic Spinal Pain in Ankylosing Spondylitis
The aim of this study is to investigate prevalence of neuropathic spinal pain in AS patients and it's impact on sleep quality. Moreover effects of neuropathic pain on quality of life and fatigue will be assessed.
- Trial name
- NCT04809168
- Testing
- Questionnaires and inventories
- Where
- Turkey (Türkiye)
- Volunteers
- 292 people
- Sponsor
- Bozyaka Training and Research Hospital
Ankylosing Spondylitis
An Open-Label Multicentre Long-Term Extension Study of Etanercept for Ankylosing Spondylitis
This study is an extension trial of 0881A3-312-EU and is designed to provide information on the safety and efficacy of etanercept in patients with ankylosing spondylitis for up to 3 additional years.
- Trial name
- NCT00444340
- Testing
- Enbrel (Etanercept)
- Volunteers
- 70 people
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
Spondyloarthritis
Study Evaluating the Effectiveness of Shiatsu on Fatigue in Patients With Axial Spondyloarthritis
Spondyloarthritis is a potentially serious disease with reduced life expectancy. Even if the clinical presentation is eminently variable from one patient to another, the most frequently encountered manifestations such as…
- Trial name
- SFASPA (NCT05433168)
- Testing
- SHIATSU, DUMMY SHIATSU
- Where
- France
- Volunteers
- 72 people
- Sponsor
- Centre Hospitalier Régional d'Orléans
Axial Spondyloarthritis
Treat to Target Trial in Axial Spondylo Arthritis : The TICOSPA (Tight Control in Spondyloarthritis)
This is a not interventional, pragmatic, prospective, randomized (cluster) study to evaluate the potential benefit of a Treat to Target approach in comparison to routine treatment (i.e.
- Trial name
- TICOSPA (NCT03043846)
- Testing
- Follow-up every 3 months during 1 year (data collection in eCRF), Follow-up every month to follow the pre-defined strategy
- Where
- 18 sites in Belgium, France and 1 more
- Volunteers
- 163 people
- Sponsor
- Association de Recherche Clinique en Rhumatologie
Rheumatoid Arthritis, Psoriatic Arthritis
PROM Collected Via a Smartphone App Versus a Touch Screen Solution Among Patients With Inflammatory Arthritis
A randomised, within-participants cross-over design trial including 60 patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis.
- Conditions
- Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis
- Trial name
- NCT03486613
- Testing
- PROM registration via the DANBIO App on a smartphone, PROM registration via the touch screen solution
- Where
- Denmark
- Volunteers
- 60 people
- Sponsor
- Salome Kristensen
Axial Spondyloarthritis, Ankylosing Spondylitis
Telerehabilitation and Face-to-Face Clinical Pilates-Based Exercise in Individuals With Axial Spondyloarthritis
Spondyloarthritis (SpA) refers to a group of rheumatic diseases that share common clinical, genetic and imaging features. They are divided into two: axial (axSpA) and peripheral.
- Trial name
- NCT05006690
- Testing
- Clinical Pilates-Based Exercise Training
- Where
- Turkey (Türkiye)
- Volunteers
- 50 people
- Sponsor
- Hacettepe University
Spondylitis
Efficacy and Safety Study of Infliximab (Remicade) to Treat Early Ankylosing Spondylitis
This is a prospective open-label study to evaluated the efficacy and safety of infliximab(Remicade) in treating of patients with early ankylosing spondylitis (AS).
- Trial name
- NCT00936143
- Testing
- infliximab
- Where
- China
- Volunteers
- 70 people
- Sponsor
- Gu Jieruo
Ankylosing Spondylitis
Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis
Assessed using (1) Adalimumab(Humira) and NSAIDs (2) Use only Adalimumab(Humira) treatment of ankylosing spondylitis patient safety and efficacy.
- Trial name
- NCT02456363
- Testing
- TNF alpha, NSAIDs and sulfasalazine
- Where
- Taiwan
- Volunteers
- 300 people
- Sponsor
- Chung Shan Medical University
Ankylosing Spondylitis, Therapeutic Agent Toxicity
A Randomized Open-labeled Study for Comparing Methods of Using Imrecoxib to Treat AS
The selective cox-2 inhibitor has been widely used in the treatment of Ankylosing spondylitis (AS). The Imrecoxib is a new cox-2 inhibitor. But the treatment strategy has not been decided yet.
- Trial name
- NCT04400786
- Testing
- intermittent treatment, continuous treatment
- Where
- China
- Volunteers
- 196 people
- Sponsor
- Shanghai Zhongshan Hospital
Ankylosing Spondylitis
Infliximab and Methotrexate in Ankylosing Spondylitis
There is a great individual variability of pharmacokinetic of infliximab in patients treated for ankylosing spondylitis (AS). Moreover, some patients have a treatment with methotrexate (MTX), others have not.
- Trial name
- SPAXIM (NCT00507403)
- Testing
- infliximab
- Where
- 2 sites in France
- Volunteers
- 30 people
- Sponsor
- University Hospital, Tours
Rheumatoid Arthritis, Psoriatic Arthritis
WORK-ON Vocational Rehabilitation for People With Inflammatory Arthritis
People with chronic inflammatory arthritis (IA) (rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis), often have a reduced work ability. Up to 40% lose their job in the first years after diagnosis.
- Conditions
- Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis
- Trial name
- WORK-ON (NCT06299917)
- Testing
- WORK-ON
- Where
- Denmark
- Volunteers
- 56 people
- Sponsor
- The Danish Center for Expertise in Rheumatology
Ankylosing Spondylitis, Psoriatic Arthritis
Functional Limitations Due To The Foot Involvement In Spondyloarthritis
Seronegative spondyloarthritis (SpA) is a group of rheumatic diseases Foot involvement of the SpA is common and enthesitis, erosive changes or ankylosis are the frequent lesions.
- Trial name
- NCT01833468
- Volunteers
- 30 people
- Sponsor
- Vakif Gureba Training and Research Hospital
Axial Spondyloarthritis (AxSpA)
A Pragmatic Trial of Interleukin-17 Inhibition Versus Janus Kinase Inhibition After Tumor Necrosis Factor-alpha Inhibitor Failure in Axial Spondyloarthritis
The purpose of this study is to determine the feasibility of conducting a pragmatic trial of IL-17i versus JAKi in adults with axial spondyloarthritis (axSpA) who have failed at least one tumor necrosis factor-alpha inhibitor…
- Trial name
- NCT07770646
- Testing
- Secukinumab (IL-17i ), Upadacitinib (JAKi)
- Where
- United States
- Volunteers
- 40 people
- Sponsor
- The University of Texas Health Science Center, Houston
Psoriatic Arthritis
A 24 Week Open Label Study of the Utility of Adalimumab in Active Axial Forms of Psoriatic Arthritis
Based on published data and according to the approved product label for ankylosing spondylitis and psoriatic arthritis, it can be expected that adalimumab 40 mg every 14 days should be effective in psoriatic arthritic patients…
- Trial name
- NCT00963313
- Testing
- Adalimumab (HUMIRA®)
- Where
- 22 sites in Spain
- Volunteers
- 29 people
- Sponsor
- Dr. FRANCISCO J. BLANCO-GARCIA
Post-Acute COVID-19 Syndrome, ME/CFS
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
The unhide® Project is a non-interventional, longitudinal research study designed to establish a secure data repository of demographic, health, and lifestyle information from individuals with brain inflammation and related…
- Conditions
- Post-Acute COVID-19 Syndrome, ME/CFS, Rheumatic Arthritis, Juvenile Rheumatoid Arthritis (JRA)
- Trial name
- NCT04806620
- Where
- United States
- Volunteers
- 10,000 people, healthy volunteers welcome
- Sponsor
- Brain Inflammation Collaborative
Ankylosing Spondylitis
Physical Training Program in Ankylosing Spondylitis
Purpose: to assess the efficacy of a physical training program in patients with ankylosing spondylitis (AS) in a randomized controlled study
- Trial name
- PEPS (NCT02284646)
- Testing
- Personalized physical training program
- Where
- France
- Volunteers
- 56 people
- Sponsor
- University Hospital, Toulouse
Ankylosing Spondylitis
An Open-Label, Multicentre, Long-Term Extension Study of Etanercept in Ankylosing Spondylitis
The primary objective of this study was to determine the long-term safety of etanercept in adults with AS who had completed study 0881A3-311-EU.
- Trial name
- NCT00421980
- Testing
- Etanercept
- Where
- Belgium
- Volunteers
- 84 people, healthy volunteers welcome
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
Rheumatoid Arthritis, Psoriatic Arthritis
INSELMA - a Randomised Controlled Trial
Background: Patients with inflammatory arthritis (IA) experience substantial impact of their disease despite optimal pharmacological treatment.
- Conditions
- Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis
- Trial name
- INSELMA-RCT (NCT06583980)
- Testing
- Interdisciplinary Nurse-coordinated self-management support for people with inflammatory arthritis and substantial disease impact
- Where
- 3 sites in Denmark
- Volunteers
- 120 people
- Sponsor
- The Danish Center for Expertise in Rheumatology
Psoriatic Arthritis, Rheumatoid Arthritis
Activating the Cholinergic Anti-Inflammatory Pathway in Healthy Volunteers and People With Inflammatory Arthritis
This study is designed to investigate whether non-invasive ultrasound (US) that is optimized for stimulation and can elicit an anti-inflammatory response in people with Inflammatory Arthritis as compared to a sham intervention.
- Conditions
- Psoriatic Arthritis, Rheumatoid Arthritis, Ankylosing Spondylitis
- Trial name
- NCT06555562
- Testing
- Ultrasound Stimulation, Non-active ultrasound stimulation
- Where
- 2 sites in United States
- Volunteers
- 16 people, healthy volunteers welcome
- Sponsor
- Surf Therapeutics
Ankylosing Spondylitis
The Effect of Fecal Microbiota Transplantation in Ankylosing Spondylitis (AS) Patients.
Ankylosing spondylitis (AS) patients often have subclinical gut wall inflammation. Gut dysbiosis has been associated with both AS and Crohn disease, both of which have several features in common.
- Trial name
- ASGUT (NCT03726645)
- Testing
- Fecal microbiota transplantation
- Where
- Finland
- Volunteers
- 20 people
- Sponsor
- Hospital District of Helsinki and Uusimaa